United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - bisoprolol fumarate - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - bisoprolol fumarate - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - bisoprolol fumarate - oral tablet - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - bisoprolol fumarate - oral tablet - 5mg

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide- derived drugs.

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals, inc. - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide- derived drugs.

United States - English - NLM (National Library of Medicine)

teva women's health llc - bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - bisoprolol fumarate 2.5 mg - ziac (bisoprolol fumarate and hydrochlorothiazide) is indicated in the management of hypertension. ziac is contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - bisoprolol fumarate - tablet - 10 milligram(s) - beta blocking agents, selective; bisoprolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

impexeco - bisoprolol fumarate - tablet - 5 mg - bisoprolol fumarate 5 mg - bisoprolol